Modern Healthcare - - Regional News -


NYU Lan­gone Med­i­cal Cen­ter, a three-cam­pus, 789-bed in­sti­tu­tion, has re­ceived an $84 mil­lion Na­tional In­sti­tutes of Health grant to con­duct a com­par­a­tive-ef­fec­tive­ness study to in­ves­ti­gate when an­gio­plasty and stent­ing are most ap­pro­pri­ate for pa­tients with coro­nary artery disease and when med­i­cal ther­apy should be the first-line ap­proach. Called the In­ter­na­tional Study of Com­par­a­tive Health Ef­fec­tive­ness with Med­i­cal and In­va­sive Ap­proaches, or IS­CHEMIA, the re­search is be­ing funded by the NIH’s Na­tional Heart, Lung and Blood In­sti­tute and will in­clude more than 150 med­i­cal cen­ters in the U.S. as well as sites in 33 other coun­tries, ac­cord­ing to a med­i­cal cen­ter news re­lease. Eight thou­sand pa­tients who have sta­ble is­chemic heart disease will par­tic­i­pate, ac­cord­ing to the re­lease. NYU Lan­gone’s Car­dio­vas­cu­lar Clin­i­cal Re­search Cen­ter will co­or­di­nate the trial, which will study whether early in­va­sive strat­egy—in this case, car­diac catheter­i­za­tion fol­lowed by med­i­cal ther­apy and life­style changes— im­proves qual­ity of life more so than be­gin­ning treat­ment with med­i­cal ther­apy and re­serv­ing in­va­sive pro­ce­dures for when con­ser­va­tive med­i­cal ther­apy fails. “The med­i­cal com­mu­nity agrees fur­ther study is nec­es­sary to bet­ter de­ter­mine the need for an in­va­sive strat­egy and the value of revas­cu­lar­iza­tion when treat­ing this pa­tient pop­u­la­tion,” Dr. Ju­dith Hochman, study chair­woman and clin­i­cal chief of NYU Lan­gone’s divi­sion of car­di­ol­ogy, said in the re­lease. “With the NIH grant, we have the op­por­tu­nity to col­lab­o­rate with other car­di­ol­ogy thought lead­ers from around the coun­try and world who share our ur­gency in learn­ing more about what ther­a­pies of­fer op­ti­mal out­comes for pa­tients in the most cost-ef­fec­tive man­ner.”

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.